The import of antisera and other blood fractions to Japan is projected to grow steadily from 2024 to 2028, starting at 3.6897 million kilograms and increasing annually. This growth indicates a consistent demand in the Japanese market, with each year showing a gradual rise—approximately 0.6% year-on-year growth, based on the data provided. As per actual data from previous years up to 2023, 2023 served as a baseline for forecasting with notable import levels.
Future trends to watch for include technological advancements in medicine that might boost demand further, potential changes in trade regulations, and the impact of global health concerns that could spur increases in imports. Moreover, shifts in local production capabilities and domestic needs may also influence future import volumes.
